Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,459 public trials 541 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Completed

Safety and Tolerance Study of Oral Doses of CT53518 to Treat Patients With Acute Myelogenous Leukemia (AML)

NCT00064584

Conditions
Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Ohio State University Medical Center Columbus, Ohio, United States
View Trial Details
Completed

Study of Low-Dose Intravenous Decitabine in Patients Aged > 60 Years With Acute Myeloid Leukemia

NCT00866073

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Medizinische Hochschule Hannover Hanover, Lower Saxony, Germany
  • Klinikum der Technischen Universität Aachen Aachen, Germany
  • Universitätsklinikum Düsseldorf Düsseldorf, Germany
  • Katholisches Krankenhaus Hagen Hagen, Germany
View Trial Details
Completed

Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result

NCT00146120

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Department of Hematology / Oncology, University Hospital of Innsbruck Innsbruck, Austria
  • III Medical Department, Hematology and Oncology Center, Hanuschhospital Wien Vienna, Austria
  • Department of General Internal Medicine, University Hospital of Bonn Bonn, Germany
  • Department of Internal Medicine Hematology, Heinrich-Heine University Düsseldorf, Germany
View all 22 locations
View Trial Details
Completed

Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid Leukemia

NCT00086099

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Scripps Cancer Center San Diego, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Cancer Care Center New Albany, Indiana, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View all 19 locations
View Trial Details

Related conditions